![]() |
市場調查報告書
商品編碼
2160844
菌絲蛋白原料市場預測至2034年-按產品類型、真菌種類、生產流程、應用、形態和地區分類的全球分析Mycelium Protein Ingredients Market Forecasts to 2034 - Global Analysis By Product, Fungal Type, Production Process, Application, Form, and Geography |
||||||
根據 Stratistics MRC 預測,全球菌絲蛋白原料市場預計到 2026 年將達到 5 億美元,並在預測期內以 30.5% 的複合年成長率成長,到 2034 年將達到 42 億美元。
菌絲蛋白原料是一種富含蛋白質的食品配料,它是透過控制培養和發酵過程,利用真菌絲狀根狀結構生產的。菌絲體提供蛋白質、膳食纖維和其他營養物質,同時其纖維結構也使其適用於食品配方。這些原料可用於肉類替代品、高蛋白食品、點心、調理食品和其他植物來源產品。根據應用需求,其天然的絲狀結構無需複雜的擠壓工藝即可製成類似肉類的質地。市場需求主要源自於人們對永續蛋白質、替代食品來源、高效能生質能生產以及改良肉類替代品配方的關注。生產商正不斷最佳化菌株、發酵條件、生質能產量、蛋白質含量、風味和質地。加工技術也不斷改進,以提升保水性、黏合性、熱性能和感官特性。新的應用領域包括肉類替代品、混合蛋白產品、機能性食品和微加工菌絲體基產品。
市場動態
對永續蛋白質來源的需求日益成長
人口成長和肉類消費增加推動了蛋白質需求的成長,這給傳統蛋白質來源帶來了壓力,同時也引發了人們對菌絲蛋白的興趣。人們對畜牧業環境影響的日益關注也促進了真菌蛋白的普及。菌絲蛋白具有更優的營養成分和永續的生產方式。對菌絲蛋白研發投入的增加正在加速其商業化進程。消費者對新型蛋白質來源的興趣也推動了市場擴張。
生產成本高且難以擴大規模
與傳統蛋白質相比,菌絲蛋白原料高昂的生產成本構成了價格競爭力障礙。從實驗室規模化生產到商業化生產的許多挑戰也影響著生產的經濟效益。有限的產能限制了產品開發和商業應用的供應。新食品配料的法規核准流程因地區而異,耗時較長。消費者對菌絲蛋白的接受度可能取決於他們對真菌的認知。
發酵技術和菌株開發的進展
發酵技術的進步使得菌絲蛋白的生產更有效率且成本更低。改良菌株的開發提高了蛋白質含量和功能性。對菌絲蛋白生產能力的投資增加正在加速其商業化進程。菌絲蛋白新應用的開發正在創造市場機會。原料生產商和食品生產商之間的合作正在拓展其潛在用途。
與其他替代蛋白的競爭
來自植物來源蛋白質和其他發酵蛋白的競爭可能會限制菌絲蛋白的普及。經濟壓力可能會影響對菌絲蛋白生產的投資。影響新食品核准的監管變化可能會影響市場發展。消費者對真菌蛋白的懷疑態度可能會影響其普及化。菌絲蛋白的快速成長將吸引新的進入者,並加劇競爭。
新冠感染疾病凸顯了傳統蛋白質供應鏈的脆弱性,並加速了人們對菌絲蛋白的興趣。消費者對永續性和食品系統韌性的日益關注正在推動市場擴張。疫情後時期,對菌絲蛋白研發的投資增加。人們對菌絲蛋白潛力的認知不斷提高,持續推動市場發展。
在預測期內,蛋白質濃縮物細分市場預計將佔據最大佔有率。
預計在預測期內,濃縮蛋白產品將佔據最大的市場佔有率。這是因為濃縮蛋白產品在食品應用上兼具良好的蛋白質含量、功能性和成本優勢。肉類替代品對菌絲體蛋白濃縮物的需求不斷成長,推動了市場擴張。下游製程的技術進步正在提升濃縮蛋白產品的品質和功能性。完善的供應體系和應用專業知識也鞏固了該領域的領先地位。
在預測期內,肉類替代品細分市場預計將呈現最高的複合年成長率。
在預測期內,受消費者對口感和質地更佳的永續肉類替代品需求不斷成長的推動,肉類替代品市場預計將呈現最高的成長率。菌絲蛋白賦予產品類似肉類的質地和鮮味,提升植物來源肉品的品質。對肉類替代品產品研發投入的增加正在加速市場擴張。肉類替代品是菌絲蛋白應用最廣泛的領域。
在預測期內,北美預計將佔據最大的市場佔有率,這主要得益於菌絲蛋白公司的強大實力以及消費者對替代蛋白日益成長的需求。美國擁有許多大型菌絲蛋白公司,並具備成熟的生產能力。食品技術投資的增加正在鞏固這些公司在該地區市場的領先地位。消費者對永續性意識的不斷提高也推動了市場擴張。
在預測期內,歐洲地區預計將呈現最高的複合年成長率,這主要得益於對永續食品創新強力的監管支持以及消費者意識的不斷提高。歐盟政策正在支持替代蛋白的開發。大量的研究經費和企業投資正在推動這些技術的商業化。人們對永續性的強烈意識正在推動菌絲蛋白在全部區域的應用。
According to Stratistics MRC, the Global Mycelium Protein Ingredients Market is accounted for $0.5 billion in 2026 and is expected to reach $4.2 billion by 2034 growing at a CAGR of 30.5% during the forecast period. Mycelium Protein Ingredients are protein-rich food ingredients produced from the filamentous root-like structures of fungi through controlled cultivation and fermentation processes. Mycelium can provide proteins, dietary fiber, and other nutritional components while offering a fibrous structure suitable for food formulation. These ingredients are used in meat alternatives, protein-rich foods, snacks, ready meals, and other plant-forward products. Their naturally filamentous structure can help create meat-like textures without requiring complex extrusion in some applications. Market demand is supported by interest in sustainable proteins, alternative food sources, efficient biomass production, and improved meat-alternative formulations. Producers increasingly optimize fungal strains, fermentation conditions, biomass yield, protein content, flavor, and texture. Processing technologies are also being developed to improve moisture retention, binding, cooking behavior, and sensory characteristics. New applications include whole-cut alternatives, hybrid protein products, functional foods, and minimally processed mycelium-based formulations.
Market Dynamics
Growing demand for sustainable protein sources
Increasing demand for protein, driven by population growth and rising meat consumption, is creating pressure on conventional protein supply and driving interest in mycelium protein. Growing awareness of the environmental impact of animal agriculture supports adoption of fungal proteins. Mycelium protein offers favorable nutritional profiles and sustainable production. Growing investment in mycelium protein research and development accelerates commercialization. Consumer interest in novel protein sources supports market expansion.
High production costs and scale-up challenges
High production costs for mycelium protein ingredients present barriers to price competitiveness with conventional proteins. Scale-up challenges from laboratory to commercial production affect production economics. Limited production capacity constrains supply availability for product development and commercial applications. Regulatory approval processes for novel food ingredients vary across regions and can be lengthy. Consumer acceptance of mycelium protein may be affected by perceptions of fungi.
Advances in fermentation technology and strain development
Advances in fermentation technology enable more efficient and cost-effective mycelium protein production. Development of improved fungal strains enhances protein content and functionality. Growing investment in mycelium protein production capacity accelerates commercialization. Expansion of mycelium protein into new applications creates market opportunities. Partnerships between ingredient companies and food manufacturers expand application possibilities.
Competition from other alternative proteins
Competition from plant-based proteins and other fermentation-derived proteins may limit mycelium protein adoption. Economic pressures may affect investment in mycelium protein production. Regulatory changes affecting novel food approval may impact market development. Consumer skepticism regarding fungal proteins may affect adoption. Rapid growth of mycelium protein attracts new entrants and intensifies competition.
The COVID-19 pandemic highlighted vulnerabilities in conventional protein supply chains, accelerating interest in mycelium protein. Growing consumer focus on sustainability and food system resilience supports market expansion. The post-pandemic period has witnessed increased investment in mycelium protein research and development. Growing recognition of mycelium protein potential continues driving market development.
The protein concentrates segment is expected to be the largest during the forecast period
The protein concentrates segment is expected to account for the largest market share during the forecast period as protein concentrates offer a balance of protein content, functionality, and cost for food applications. Growing demand for mycelium protein concentrates in meat alternatives drives market expansion. Advances in downstream processing improve concentrate quality and functionality. Established supply infrastructure and application knowledge support segment leadership.
The meat alternatives segment is expected to have the highest CAGR during the forecast period
Over the forecast period, the meat alternatives segment is predicted to witness the highest growth rate driven by growing consumer demand for sustainable meat alternatives with improved taste and texture. Mycelium protein offers meat-like texture and umami flavor that enhances plant-based meat products. Growing investment in meat alternative product development accelerates market expansion. Meat alternatives represent the largest application for mycelium protein.
During the forecast period, the North America region is expected to hold the largest market share owing to strong presence of mycelium protein companies and growing consumer demand for alternative proteins. The United States hosts major mycelium protein companies with established production capabilities. Growing investment in food technology reinforces regional market leadership. High consumer awareness of sustainability supports market expansion.
Over the forecast period, the Europe region is anticipated to exhibit the highest CAGR driven by strong regulatory support for sustainable food innovation and growing consumer awareness. European Union policies support alternative protein development. Significant research funding and corporate investment support technology commercialization. Strong sustainability culture drives adoption of mycelium protein across the region.
Key players in the market
Some of the key players in the Mycelium Protein Ingredients Market include MycoTechnology, Inc., Quorn Foods, Nature's Fynd, ENOUGH, Prime Roots, Infinite Roots, Meati Foods, Libre Foods, MyForest Foods, Kinoko-Tech, The Better Meat Co., Mycorena, Adamo Foods, Fungi Perfecti, and Mushlabs.
In August 2026, Nature's Fynd announced the commercial launch of its mycelium protein ingredient for meat alternative applications following successful regulatory approval. The ingredient offers high protein content and meat-like texture. This launch represents a major milestone in mycelium protein commercialization.
In May 2026, ENOUGH announced the expansion of its mycoprotein production capacity in Europe to meet growing demand from food manufacturers. The expansion includes new fermentation and downstream processing facilities. This investment responds to accelerating demand for sustainable protein ingredients.
In February 2026, MycoTechnology, Inc. launched a new range of mycelium protein ingredients for dairy alternative applications. The products offer improved taste and texture compared to earlier generations. This launch addresses growing demand for fermentation-derived proteins.
In November 2025, Meati Foods announced the expansion of its mycelium protein production capacity with a new facility in the United States. The facility will produce mycelium-based meat alternatives at commercial scale. This investment responds to growing consumer demand.
In July 2025, Quorn Foods introduced a new line of mycelium protein ingredients for food manufacturers. The products offer consistent quality and functionality for diverse applications. This launch addresses growing demand for mycelium protein from food companies.
In March 2025, Prime Roots launched a new mycelium-based deli meat product. The product offers taste and texture comparable to conventional deli meats. This launch addresses growing demand for sustainable meat alternatives.
Note: Tables for North America, Europe, APAC, South America, and Rest of the World (RoW) are also represented in the same manner as above.